Search

everythinglearnresearchcommunity

for

Search:↓

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Younger people may have a higher risk of hair loss due to poor nutrition and lifestyle.

JAK inhibitors offer new hope for treating severe alopecia areata.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Exosome therapy could be a promising new way to treat hair loss.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Two microRNAs in stem cell exosomes help treat hair loss by targeting a specific signaling pathway.

Inflammatory diets may increase the risk and severity of alopecia areata.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Low-level laser therapy effectively improves hair growth in androgenetic alopecia with minimal side effects.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

A woman regrew her hair after receiving injections of special cell-derived vesicles.